BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

355 related articles for article (PubMed ID: 29728406)

  • 1. B-cell differentiation and IL-21 response in
    Miggelbrink AM; Logan BR; Buckley RH; Parrott RE; Dvorak CC; Kapoor N; Abdel-Azim H; Prockop SE; Shyr D; Decaluwe H; Hanson IC; Gillio A; Dávila Saldaña BJ; Eibel H; Hopkins G; Walter JE; Whangbo JS; Kohn DB; Puck JM; Cowan MJ; Griffith LM; Haddad E; O'Reilly RJ; Notarangelo LD; Pai SY
    Blood; 2018 Jun; 131(26):2967-2977. PubMed ID: 29728406
    [TBL] [Abstract][Full Text] [Related]  

  • 2. IL-21 is the primary common γ chain-binding cytokine required for human B-cell differentiation in vivo.
    Recher M; Berglund LJ; Avery DT; Cowan MJ; Gennery AR; Smart J; Peake J; Wong M; Pai SY; Baxi S; Walter JE; Palendira U; Tangye GA; Rice M; Brothers S; Al-Herz W; Oettgen H; Eibel H; Puck JM; Cattaneo F; Ziegler JB; Giliani S; Tangye SG; Notarangelo LD
    Blood; 2011 Dec; 118(26):6824-35. PubMed ID: 22039266
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term outcome of hematopoietic stem cell transplantation for IL2RG/JAK3 SCID: a cohort report.
    Abd Hamid IJ; Slatter MA; McKendrick F; Pearce MS; Gennery AR
    Blood; 2017 Apr; 129(15):2198-2201. PubMed ID: 28209722
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Defects in mucosal immunity and nasopharyngeal dysbiosis in HSC-transplanted SCID patients with IL2RG/JAK3 deficiency.
    Goncalves P; Doisne JM; Eri T; Charbit B; Bondet V; Posseme C; Llibre A; Casrouge A; Lenoir C; Neven B; Duffy D; Fischer A; Di Santo JP;
    Blood; 2022 Apr; 139(17):2585-2600. PubMed ID: 35157765
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-Term Outcomes of Hematopoietic Stem Cell Transplantation for ZAP70 Deficiency.
    Cuvelier GD; Rubin TS; Wall DA; Schroeder ML
    J Clin Immunol; 2016 Oct; 36(7):713-24. PubMed ID: 27438785
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hypomorphic Janus kinase 3 mutations result in a spectrum of immune defects, including partial maternal T-cell engraftment.
    Cattaneo F; Recher M; Masneri S; Baxi SN; Fiorini C; Antonelli F; Wysocki CA; Calderon JG; Eibel H; Smith AR; Bonilla FA; Tsitsikov E; Giliani S; Notarangelo LD; Pai SY
    J Allergy Clin Immunol; 2013 Apr; 131(4):1136-45. PubMed ID: 23384681
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impaired IL-7 signaling may explain a case of atypical JAK3-SCID.
    Li J; Nara H; Rahman M; Juliana FM; Araki A; Asao H
    Cytokine; 2010 Feb; 49(2):221-8. PubMed ID: 19889552
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Current Knowledge and Priorities for Future Research in Late Effects after Hematopoietic Stem Cell Transplantation (HCT) for Severe Combined Immunodeficiency Patients: A Consensus Statement from the Second Pediatric Blood and Marrow Transplant Consortium International Conference on Late Effects after Pediatric HCT.
    Heimall J; Puck J; Buckley R; Fleisher TA; Gennery AR; Neven B; Slatter M; Haddad E; Notarangelo LD; Baker KS; Dietz AC; Duncan C; Pulsipher MA; Cowan MJ
    Biol Blood Marrow Transplant; 2017 Mar; 23(3):379-387. PubMed ID: 28068510
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Successful haploidentical hematopoietic stem cell transplantation in a patient with SCID due to CD3ε deficiency: need for IgG-substitution 6 years later.
    Fuehrer M; Pannicke U; Schuetz C; Jacobsen EM; Schulz A; Friedrich W; Schwarz K; Hönig M
    Klin Padiatr; 2014 May; 226(3):149-53. PubMed ID: 24515816
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intact B-Cell Signaling and Function With Host B-Cells 47 Years After Transplantation for X-SCID.
    Deal C; Thauland TJ; Stiehm ER; Garcia-Lloret MI; Butte MJ
    Front Immunol; 2020; 11():415. PubMed ID: 32265911
    [No Abstract]   [Full Text] [Related]  

  • 11. Host natural killer immunity is a key indicator of permissiveness for donor cell engraftment in patients with severe combined immunodeficiency.
    Hassan A; Lee P; Maggina P; Xu JH; Moreira D; Slatter M; Nademi Z; Worth A; Adams S; Jones A; Cale C; Allwood Z; Rao K; Chiesa R; Amrolia P; Gaspar H; Davies EG; Veys P; Gennery A; Qasim W
    J Allergy Clin Immunol; 2014 Jun; 133(6):1660-6. PubMed ID: 24794685
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Humoral Immune Reconstitution Kinetics after Allogeneic Hematopoietic Stem Cell Transplantation in Children: A Maturation Block of IgM Memory B Cells May Lead to Impaired Antibody Immune Reconstitution.
    Abdel-Azim H; Elshoury A; Mahadeo KM; Parkman R; Kapoor N
    Biol Blood Marrow Transplant; 2017 Sep; 23(9):1437-1446. PubMed ID: 28495643
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Patients with T⁺/low NK⁺ IL-2 receptor γ chain deficiency have differentially-impaired cytokine signaling resulting in severe combined immunodeficiency.
    Fuchs S; Rensing-Ehl A; Erlacher M; Vraetz T; Hartjes L; Janda A; Rizzi M; Lorenz MR; Gilmour K; de Saint-Basile G; Roifman CM; Cheuk S; Gennery A; Thrasher AJ; Fuchs I; Schwarz K; Speckmann C; Ehl S
    Eur J Immunol; 2014 Oct; 44(10):3129-40. PubMed ID: 25042067
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Atypical immune phenotype in severe combined immunodeficiency patients with novel mutations in IL2RG and JAK3.
    Goldberg L; Simon AJ; Lev A; Barel O; Stauber T; Kunik V; Rechavi G; Somech R
    Genes Immun; 2020 Nov; 21(5):326-334. PubMed ID: 32921793
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Competition within the early B-cell compartment conditions B-cell reconstitution after hematopoietic stem cell transplantation in nonirradiated recipients.
    Liu A; Vosshenrich CA; Lagresle-Peyrou C; Malassis-Seris M; Hue C; Fischer A; Di Santo JP; Cavazzana-Calvo M
    Blood; 2006 Aug; 108(4):1123-8. PubMed ID: 16614244
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Case Report: A Novel IL2RG Frame-Restoring Rescue Mutation Mimics Early T Cell Engraftment Following Haploidentical Hematopoietic Stem Cell Transplantation in a Patient With X-SCID.
    Steininger J; Leiss-Piller A; Geier CB; Rossmanith R; Elfeky R; Bra D; Pichler H; Lawitschka A; Zubarovskaya N; Artacker G; Matthes-Leodolter S; Eibl MM; Wolf HM
    Front Immunol; 2021; 12():644687. PubMed ID: 33959125
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Allogeneic hematopoietic stem cell transplantation in two brothers with DNA ligase IV deficiency: a case report and review of the literature.
    Schober S; Schilbach K; Doering M; Cabanillas Stanchi KM; Holzer U; Kasteleiner P; Schittenhelm J; Schaefer JF; Mueller I; Lang P; Handgretinger R
    BMC Pediatr; 2019 Oct; 19(1):346. PubMed ID: 31604460
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transplantation of X-linked severe combined immunodeficient dogs with CD34+ bone marrow cells.
    Hartnett BJ; Yao D; Suter SE; Ellinwood NM; Henthorn PS; Moore PE; McSweeney PA; Nash RA; Brown JD; Weinberg KI; Felsburg PJ
    Biol Blood Marrow Transplant; 2002; 8(4):188-97. PubMed ID: 12014808
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular diagnosis of severe combined immunodeficiency--identification of IL2RG, JAK3, IL7R, DCLRE1C, RAG1, and RAG2 mutations in a cohort of Chinese and Southeast Asian children.
    Lee PP; Chan KW; Chen TX; Jiang LP; Wang XC; Zeng HS; Chen XY; Liew WK; Chen J; Chu KM; Chan LL; Shek L; Lee AC; Yu HH; Li Q; Xu CG; Sultan-Ugdoracion G; Latiff ZA; Latiff AH; Jirapongsananuruk O; Ho MH; Lee TL; Yang XQ; Lau YL
    J Clin Immunol; 2011 Apr; 31(2):281-96. PubMed ID: 21184155
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immune reconstitution after HSCT in SCID-a cohort of conditioned and unconditioned patients.
    Manor U; Lev A; Simon AJ; Hutt D; Toren A; Bielorai B; Goldberg L; Stauber T; Somech R
    Immunol Res; 2019 Jun; 67(2-3):166-175. PubMed ID: 31222511
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.